Similarly, peptide vaccination of OVA synthetic long peptide (SLP) fused with XCL1 led to greater tumor control of B16-OVA melanoma tumors with higher CD8 T cell tumor infiltration (185). The gene discussed is XCL1; the disease is neoplasm.